Fenretinide Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Small Cell Lung Cancer
SciTech Development, Inc.44 enrolled1 locationNCT06922539
Recruiting
Phase 1
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
T-cell LymphomaCutaneous/Peripheral T-Cell Lymphoma
SciTech Development, Inc.46 enrolled10 locationsNCT04234048